SIETES :: 92257 citas

Resultados de la búsqueda por ANAFILAXIA REFINAR BÚSQUEDA

1.

Montané E, Arellano AL, Sanz Y, Roca J, Farré M. Drug-related deaths in hospital inpatients: a retrospective cohort study. Br J Clin Pharmacol 2017;84:1. [Ref.ID 102184]

2.

Trubiano JA, Adkinson NF, Phillips EJ. Penicillin allergy Is not necessarily forever. JAMA 2017;318:82-3. [Ref.ID 102053]

3.

Anónimo. Antiseptic Linked To Severe Allergic Reactions, FDA Says. MedPage Today (2/2, Gever) reports the Food and Drug Administration warned that “antiseptic solutions, washes, sponges, and other products containing chlorhexidine gluconate may carry a slight risk of causing severe allergic reactions including anaphylaxis.” The FDA “identified 52 cases of anaphylaxis in individuals worldwide in the past 70 years who had used chlorhexidine gluconate products, including two fatalities.” The FDA advised if allergic potential is suspected, healthcare professionals should use “povidone-iodine, alcohols, benzalkonium chloride, benzethonium chloride, or paracholometaxylenol.” . DIA Daily 2017:5. [Ref.ID 101386]

4.

Wang C, Wong S, Graham DJ. Risk of anaphylaxis with intravenous iron products. JAMA 2016;315:2232-3. [Ref.ID 100367]

5.

DeLoughery TG. Risk of anaphylaxis with intravenous iron products. JAMA 2016;315:2232. [Ref.ID 100366]

6.

Anónimo. Fusafungina (Fusaloyos®): Recomendación de suspensión de comercialización. Recomendaciones del Comité para la Evaluación de Riesgos en Farmacovigilancia europeo (PRAC). Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) 2016:12 de febrero. [Ref.ID 100006]

7.

Wang C, Graham DJ, Kane RC, Xie D, Wemecke M, Levenson M, MaCurdy TE, Houstoun M, Ryan Q, Wong S, Mott K, Sheu T-C, Limb S, Worrall C, Kelman JA, Reichman ME. Comparative risk of anaphylactic reactions associated with intravenous iron products. JAMA 2015;314:2062-8. [Ref.ID 99687]

8.

Anónimo. Drugs for the doctor's bag: 2-children. Drug Ther Bull 2015;53:69-72. [Ref.ID 99214]

9.

Macy E, Contreras R. Adverse reactions associated with oral and parenteral use of cephalosporins: A retrospective population-based analysis. J Allergy Clin Immunol 2015;135:745-52. [Ref.ID 98852]

10.

Vivolo M, Blanca M, Sabino Garro L, Rosimeire Ribero M, Kalil J, Motta AA, Castells M, Giavina-Bianchi P. Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis. J Allergy Clin Immunol 2014;2:414-20. [Ref.ID 97907]

11.

Anónimo. Over-the-counter topical acne products: drug safety communication - Rare but serious hypersensitivity reactions. FDA U.S. Food and Drug Administration 2014:25 de junio. [Ref.ID 97713]

12.

Anónimo. Néfopam: un bilan français. Prescrire 2013;33:825. [Ref.ID 96494]

13.

Phizackerley D. Ace vulgaris. Don't use minocycline?. BMJ 2013;347:21-2. [Ref.ID 96147]

14.

Aubin F, Carbonnel F, Wendling D. The complexity of adverse side-effects to biological agents. Journal of Crohn's and Colitis 2013;7:257-62. [Ref.ID 96072]

15.

Macartney K, Chiu C, Georgousakis M, Brotherton JML. Safety of human papillomavirus vaccines: a review. Drug Saf 2013;36:393-412. [Ref.ID 95663]

16.

Anónimo. Omalizumab (Xolair) for chronic urticaria. Med Lett Drugs Ther 2013;55:43-4. [Ref.ID 95661]

17.

Anónimo. Anaphylaxies en cours d'anesthésie: curares, latex et antibiotiques. Prescrire 2013;33:28-9. [Ref.ID 94678]

18.

Anónimo. Etifoxine: trop d'effets indésirables graves. Prescrire 2013;33:25. [Ref.ID 94676]

19.

Anónimo. Cephalosporins for patients with penicillin allergy. Med Lett Drugs Ther 2012;54:101-3. [Ref.ID 94273]

20.

Anónimo. Hypersensibilité croisée entre pholcodine et suxaméthonium. Prescrire 2012;32:830. [Ref.ID 93978]